• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤结节性多动脉炎和肺动脉高压:意想不到的关联。病例报告。

Cutaneous polyarteritis nodosa and pulmonary arterial hypertension: An unexpected liaison. A case report.

机构信息

Department of Interdisciplinary Medicine, Internal Medicine Unit, "Aldo Moro" University of Bari Medical School, Bari, Italy.

Centre for Medical Sciences, University of Trento and Internal Medicine Unit, Santa Chiara Hospital, Provincial Health Care Agency (APSS), Trento, Italy.

出版信息

Medicine (Baltimore). 2023 Dec 15;102(50):e36563. doi: 10.1097/MD.0000000000036563.

DOI:10.1097/MD.0000000000036563
PMID:38115264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10727645/
Abstract

BACKGROUND

Cutaneous polyarteritis nodosa (cPAN) is a form of medium-sized vessel necrotizing vasculitis. It is a rare, skin-limited variant of polyarteritis nodosa, characterized by dermal and subcutaneous tissue involvement. The most common findings in cPAN include digital gangrene, livedo reticularis, and tender subcutaneous nodules. However, while limited to the skin, cPAN results in significant morbidity and mortality due to the accompanying skin ischemia and necrosis, such that patients are vulnerable to superinfection. Here, we describe a unique presentation of cPAN associated with pulmonary arterial hypertension (PAH).

METHODS

A 78-year-old female presented with digital ischemia and leg ulcers associated with PAH. Skin biopsy showed necrotizing fibrinoid necrosis of the small- and middle-sized vessels of the dermis. A diagnosis of cPAN and PAH was made. The patient was treated with glucocorticoids, vasodilators, and cyclophosphamide.

RESULTS

She died due to severe sepsis complications.

CONCLUSION

To date, this is the first case report describing the association between cPAN and PAH. In this case, PAH is a complication of the cutaneous vasculitides suggesting that vasculopathy could play a role in the pathophysiology of PAH. However, the underlying pathophysiological mechanisms still have to be firmly established.

摘要

背景

皮肤型多发性动脉炎(cutaneous polyarteritis nodosa,cPAN)是一种中等大小血管坏死性血管炎。它是一种罕见的皮肤局限性多发性动脉炎,其特征是真皮和皮下组织受累。cPAN 最常见的表现包括指端坏疽、网状青斑和触痛性皮下结节。然而,尽管局限于皮肤,cPAN 仍会因伴随的皮肤缺血和坏死而导致显著的发病率和死亡率,使患者易发生继发感染。在这里,我们描述了一例与肺动脉高压(pulmonary arterial hypertension,PAH)相关的 cPAN 独特表现。

方法

一名 78 岁女性因 PAH 出现指端缺血和腿部溃疡。皮肤活检显示真皮中小血管的纤维蛋白样坏死。诊断为 cPAN 和 PAH。患者接受了糖皮质激素、血管扩张剂和环磷酰胺治疗。

结果

她因严重败血症并发症死亡。

结论

迄今为止,这是首例描述 cPAN 和 PAH 之间关联的病例报告。在本例中,PAH 是皮肤血管炎的并发症,提示血管病变可能在 PAH 的病理生理学中起作用。然而,潜在的病理生理机制仍需进一步确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a534/10727645/1363c8d23a24/medi-102-e36563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a534/10727645/ce126fd89ce3/medi-102-e36563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a534/10727645/a942c96cc0ed/medi-102-e36563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a534/10727645/1363c8d23a24/medi-102-e36563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a534/10727645/ce126fd89ce3/medi-102-e36563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a534/10727645/a942c96cc0ed/medi-102-e36563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a534/10727645/1363c8d23a24/medi-102-e36563-g003.jpg

相似文献

1
Cutaneous polyarteritis nodosa and pulmonary arterial hypertension: An unexpected liaison. A case report.皮肤结节性多动脉炎和肺动脉高压:意想不到的关联。病例报告。
Medicine (Baltimore). 2023 Dec 15;102(50):e36563. doi: 10.1097/MD.0000000000036563.
2
Cutaneous polyarteritis nodosa: A rare isolated cutaneous vasculitis.皮肤结节性多动脉炎:一种罕见的孤立性皮肤血管炎。
Indian Dermatol Online J. 2012 Jan;3(1):21-4. doi: 10.4103/2229-5178.93488.
3
Cutaneous polyarteritis nodosa presented with digital gangrene: a case report.结节性多动脉炎伴指端坏疽:一例报告
J Korean Med Sci. 2006 Apr;21(2):371-3. doi: 10.3346/jkms.2006.21.2.371.
4
Cutaneous polyarteritis nodosa sine nodosa.皮肤型结节性多动脉炎。
J Cutan Med Surg. 2014 Nov;18(6):420-3. doi: 10.2310/7750.2014.13165.
5
A case report of cutaneous polyarteritis nodosa in siblings.结节性多动脉炎累及同胞兄妹的病例报告
Mod Rheumatol. 2018 Nov;28(6):1049-1052. doi: 10.1080/14397595.2016.1189139. Epub 2016 Jun 14.
6
Ulcerative cutaneous polyarteritis nodosa treated with mycophenolate mofetil and pentoxifylline.环孢菌素治疗溃疡性皮肤结节性多动脉炎的疗效观察。
J Dermatolog Treat. 2011 Jun;22(3):175-7. doi: 10.3109/09546631003636809. Epub 2010 Jul 28.
7
Cutaneous polyarteritis nodosa in a child and a review of the literature.儿童皮肤结节性多动脉炎及文献综述
Acta Paediatr. 1998 Mar;87(3):351-3. doi: 10.1080/08035259850157471.
8
Burn Center Management of Severe Necrotic Cutaneous Polyarteritis Nodosa in a Patient With a History of Thymoma.胸腺瘤病史患者严重坏死性皮肤结节性多动脉炎的烧伤中心管理
Cureus. 2021 Feb 4;13(2):e13134. doi: 10.7759/cureus.13134.
9
Gangrenous digital infarcts in a severe case of cutaneous polyarteritis nodosa.严重皮肤结节性多动脉炎病例中的坏疽性指端梗死。
BMJ Case Rep. 2017 Jun 29;2017:bcr-2017-220300. doi: 10.1136/bcr-2017-220300.
10
Successful treatment of cutaneous polyarteritis nodosa with baricitinib.巴瑞替尼成功治疗皮肤结节性多动脉炎。
J Dermatolog Treat. 2024 Dec;35(1):2417965. doi: 10.1080/09546634.2024.2417965. Epub 2024 Nov 7.

引用本文的文献

1
Prevalence, molecular mechanisms and diagnostic approaches to pulmonary arterial hypertension in connective tissue diseases.结缔组织病相关肺动脉高压的患病率、分子机制及诊断方法
Rheumatol Int. 2025 Apr 4;45(4):87. doi: 10.1007/s00296-025-05845-z.

本文引用的文献

1
Livedoid vasculopathy - A diagnostic and therapeutic challenge.萎缩性硬化性苔藓样血管病——诊断与治疗的挑战。
Front Med (Lausanne). 2022 Oct 3;9:1012178. doi: 10.3389/fmed.2022.1012178. eCollection 2022.
2
Cutaneous polyarteritis nodosa diagnosis and treatment: A retrospective case series.结节性多动脉炎的皮肤表现:回顾性病例系列研究。
J Am Acad Dermatol. 2022 Dec;87(6):1370-1373. doi: 10.1016/j.jaad.2022.06.009. Epub 2022 Jun 14.
3
Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.肺动脉高压的诊断与治疗:综述
JAMA. 2022 Apr 12;327(14):1379-1391. doi: 10.1001/jama.2022.4402.
4
Therapeutic options for cutaneous polyarteritis nodosa: a systematic review.治疗皮肤结节性多动脉炎的方法:系统评价。
Rheumatology (Oxford). 2021 Sep 1;60(9):4039-4047. doi: 10.1093/rheumatology/keab402.
5
Pulmonary hypertension in connective tissue diseases, new evidence and challenges.结缔组织病相关性肺动脉高压:新证据与新挑战。
Eur J Clin Invest. 2021 Apr;51(4):e13453. doi: 10.1111/eci.13453. Epub 2020 Dec 5.
6
Manifestations, clinical course and prognostic markers in cutaneous polyarteritis nodosa.皮肤结节性多动脉炎的临床表现、临床病程及预后标志物
J Dtsch Dermatol Ges. 2020 Nov;18(11):1250-1259. doi: 10.1111/ddg.14271. Epub 2020 Oct 4.
7
Cutaneous manifestations of HAV, HBV, HCV.甲型肝炎病毒、乙型肝炎病毒、丙型肝炎病毒的皮肤表现
Ital J Dermatol Venerol. 2021 Feb;156(1):5-12. doi: 10.23736/S2784-8671.19.06488-5. Epub 2019 Dec 4.
8
Analysis of the Clinical Characteristics and Follow-up Study of Children with Cutaneous Polyarteritis Nodosa.儿童皮肤型结节性多动脉炎的临床特征分析及随访研究
Curr Neurovasc Res. 2019;16(3):208-214. doi: 10.2174/1567202616666190618112705.
9
Pulmonary manifestations of large, medium, and variable vessel vasculitis.大、中、小血管血管炎的肺部表现。
Respir Med. 2018 Dec;145:182-191. doi: 10.1016/j.rmed.2018.11.003. Epub 2018 Nov 10.
10
Clinical and Laboratory Markers Associated With Relapse in Cutaneous Polyarteritis Nodosa.与皮肤结节性多动脉炎复发相关的临床和实验室标志物。
JAMA Dermatol. 2018 Aug 1;154(8):922-926. doi: 10.1001/jamadermatol.2018.1601.